Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014–2018) Using RE-AIM

by Gita A. Toyserkani, Linda Huynh, Linda Huynh, Elaine H. Morrato, Elaine H. Morrato
Published 2020-02-01

Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014–2018)

by Linda Huynh, Gita A. Toyserkani, Elaine H. Morrato
Published 2021-08-01

Temporal Changes in Cortical and Hippocampal Expression of Genes Important for Brain Glucose Metabolism Following Controlled Cortical Impact Injury in Mice

by June Zhou, June Zhou, Mark P. Burns, Linda Huynh, Sonia Villapol, Daniel D. Taub, Daniel D. Taub, Juan M. Saavedra, Marc R. Blackman, Marc R. Blackman, Marc R. Blackman, Marc R. Blackman
Published 2017-09-01

Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.

by Jean K Lim, Andrea Lisco, David H McDermott, Linda Huynh, Jerrold M Ward, Bernard Johnson, Hope Johnson, John Pape, Gregory A Foster, David Krysztof, Dean Follmann, Susan L Stramer, Leonid B Margolis, Philip M Murphy
Published 2009-02-01